Skip to search formSkip to main contentSkip to account menu

PHA 543,613

Known as: PHA-543613, PHA543613, PHA-543,613 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
SPINAL ACTIVATION OF ALPHA 7-NICOTINIC ACETYLCHOLINE 3 RECEPTOR ATTENUATES POSTTRAUMATIC STRESS
11 Abstract—The high prevalence of chronic pain in posttraumatic stress disorder (PTSD) individuals has been widely reported by… 
2014
2014
Inhibitory effects of beta-amyloid on the nicotinic receptors which stimulate glutamate release in rat hippocampus: the glial contribution.
2014
2014
Effects of PHA-543613 on the Rodent Anterior Cingulate Cortex: a Study in Rodent Schizophrenia
2014
2014
Abstract 3948: The role of α7 nicotinic acetylcholine receptor activation and pharmacologic tobacco cessation agents on response to radiotherapy
Purpose: Tobacco use is associated with poor therapeutic outcome because it in part decreases the efficacy of conventional cancer… 
2013
2013
Neuronal nicotinic receptors as targets for enhancing cognition in schizophrenia
Review
2007
Review
2007
Novel High-Affinity 7 Neuronal Nicotinic Receptor Agonist : Radioligand Binding Characterization to Rat and Human Brain
Receptor binding was characterized for [H](1S,4S)-2,2-dimethyl5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane ([H… 
2006
2006
Method for enantiomeric purity of a quinuclidine candidate drug by capillary electrophoresis.
A chiral procedure based on EKC was developed and validated for determination of the enantiomeric purity of PHA-543613, a drug… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)